Allogeneic mesenchymal stem cell therapy with laromestrocel in mild Alzheimer’s disease: a randomized controlled phase 2a trial

Overview of attention for article published in Nature Medicine, March 2025

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news: 36 news outlets
blogs: 3 blogs
twitter: 40 X users
facebook: 1 Facebook page

wikipedia: 1 Wikipedia page
video: 1 YouTube creator
bluesky: 5 Bluesky users

Readers on

mendeley: 95 Mendeley

So far, Altmetric has seen 45 X posts from 40 X users, with an upper bound of 9,634,600 followers.

@ragheeb40 @Madam_Mito @Nature The Longeveron Phase 2a CLEAR MIND trial (Lomecel-B/laromestrocel) for mild Alzheimer's: https://t.co/EzUU1XWJc1 Full results published in Nature Medicine: https://t.co/rtfMtOUPDh

نشرت مجلة Nature Medicine (مارس 2025) نتائج تجربة سريرية مزدوجة التعمية استخدمت العلاج الخلوي Laromestrocel (Lomecel-B) لمرضى الزهايمر الخفيف. النتائج أظهرت: 🔹 تباطؤ ضمور الدماغ بنسبة 48٪ والحُصين 62٪ 🔹 تحسّن إدراكي (MoCA و MMSE) https://t.co/HAtQAxOpwD

$LGVN you’re gonna let this one run away too huh $XBI https://t.co/17l5qSPsf1

$LGVN all the features you're looking for from that pine tree ticker you're chasing. $XBI https://t.co/nCmnwIuIg4 https://t.co/C4TOjPu7Gy

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 41 additional X posts.